A report from IQVIA shows China gaining ground in cancer drug R&D, and a growing industry focus on new drug targets.
Cancer R&D is shifting — here’s what’s changing most
A report from IQVIA shows China gaining ground in cancer drug R&D, and a growing industry focus on new drug targets.
